SCHEMBL26340805

SCHEMBL26340805

Cc1ccccc1C1CCC[C@@H](OC(=N)c2ccc(N(C)C)cc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ DDB1 Q16531 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ HPGD P15428 3/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HBB P68871 1/20 0.33
▸ SLC18A3 Q16572 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PROKR1 Q8TCW9 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26340378 0.89 ALDH1A1 (0.42) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL26340042 0.76 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL26340737 0.76 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL23005309 0.69 DDB1 (0.46) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL25771217 0.69 DDB1 (0.46) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL2329301 0.61 DDB1 (0.54) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL15874850 0.60 DDB1 (0.53) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL29973239 0.60 DDB1 (0.53) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL24815345 0.60 DDB1 (0.53) ALDH1A1KDM4EDDB1CRBNHPGD
SCHEMBL4132442 0.60 DDB1 (0.53) ALDH1A1KDM4EDDB1CRBNHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303481-A1 LONG-ACTING LOW-ADDICTION HNK DERIVATIVE AND PREPARATION METHOD THEREFOR SHENZHEN RUIJIAN BIOTECHNOLOGY CO., LTD (CN) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303481-A1 LONG-ACTING LOW-ADDICTION HNK DERIVATIVE AND PREPARATION METHOD THEREFOR OPRK1, OPRL1, NTRK1 ALDH1A1 3380/4885KDM4E 3375/4885DDB1 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback